Related Articles
A novel molecular mechanism for anticancer drug-induced ovarian failure: Irinotecan HCl, an anticancer topoisomerase I inhibitor, induces specific FasL expression in granulosa cells of large ovarian follicles to enhance follicular apoptosis
Serum follicle‑stimulating hormone level is associated with human epidermal growth factor receptor type 2 and Ki67 expression in post‑menopausal females with breast cancer
Direct effects of CPT-11 and SN38 on ovarian granulosa cells
Primary ovarian insufficiency associated with lenvatinib therapy in a patient with hepatocellular carcinoma: A case report
Gonadotropins promote human ovarian cancer cell migration and invasion via a cyclooxygenase 2-dependent pathway